SelectQuote Inc Stock News

SelectQuote offers a range of insurance products, including Medicare Advantage, life, home, and auto insurance, making it a versatile broker. The company is also expanding strongly into pharmacy fulfillment through the buildout of SelectRx. The market had a strong negative reaction to the results for the fiscal year ended 6/30/24 and guidance provided.

Net income missed an analyst's estimate, while revenue beat. The company's guidance for fiscal 2025 appears to have come up short of expectations by a healthy margin.

SelectQuote, Inc. (NYSE:SLQT ) Q4 2024 Earnings Conference Call September 13, 2024 8:30 AM ET Company Participants Matt Gunter - IR Tim Danker - CEO Ryan Clement - CFO Bob Grant - President Bill Grant - COO Conference Call Participants Ben Hendrix - RBC Capital Markets Patrick McCann - Noble Capital Markets Operator Hello, and welcome to SelectQuote's Fourth Quarter Earnings Conference Call. Al...

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the fourth quarter of fiscal year 2024 of $307.2 million compared to consolidated revenue for the fourth quarter of fiscal year 2023 of $221.8 million. Consolidated net loss for the fourth quarter of fiscal year 2024 was $31.0 million compared to consolidated net loss for the fourth quarter of...

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced it will release its fourth quarter and full year 2024 financial results before market open on Friday, September 13, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, w...

Small-cap stocks have underperformed the broad market for years but are poised to rebound soon. The FOMC has all but committed to its first interest rate cut since 2020, ushering in a new age for stocks.

Finding promising, affordable stocks can yield substantial returns while making investments. Here, the focus is on three bargain stocks under $15, poised for considerable growth by 2026.

The growth stock sector has performed variably across different industries. Technology, healthcare and consumer discretionary sectors continue to offer opportunities.